<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.eurjchem.com/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-04-23T10:49:04Z</responseDate>
	<request identifier="oai:ojs.www.eurjchem.com:article/1084" metadataPrefix="oai_dc" verb="GetRecord">https://www.eurjchem.com/index.php/eurjchem/oai</request>
	<GetRecord>
		<record>
			<header>
				<identifier>oai:ojs.www.eurjchem.com:article/1084</identifier>
				<datestamp>2014-09-30T03:41:50Z</datestamp>
				<setSpec>eurjchem:ART</setSpec>
				<setSpec>driver</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Investigate the level of IL-8 in patients with diabetes mellitus and its relation with lipid profile and the incidence of atherosclerosis</dc:title>
	<dc:creator>Ibrahim, Ammal Esmaeel</dc:creator>
	<dc:subject xml:lang="en-US">Cholesterol</dc:subject>
	<dc:subject xml:lang="en-US">Triglycerides</dc:subject>
	<dc:subject xml:lang="en-US">Interleukin-8</dc:subject>
	<dc:subject xml:lang="en-US">Atherosclerosis</dc:subject>
	<dc:subject xml:lang="en-US">Body mass index</dc:subject>
	<dc:subject xml:lang="en-US">Diabetes mellitus</dc:subject>
	<dc:description xml:lang="en-US">IL-8 is a member of the CXC class of chemokines and is chemotactic for neutrophils. The cellular activation of IL-8 takes place after IL-8 binding to its receptor in the presence of calcium and protein kinase, leading to neutrophil activation and chemo taxis in infection and inﬂammation. Therefore, IL-8 tasks to mediate neutrophil recruitment, accumulation, and activation. The study included 50 patients with diabetes mellitus divided into a female group, which contained 16 female patients with an age range of 39-69 years, and a male group which contained 34 male patients with an age range of 40-72 years. Control groups contained forty healthy individuals divided into a female group, which contained 16 healthy females with an age range of 35-68 years, and a male group which contained 24 males with an age range of 39-69 years. ELISA kits were used to measure insulin and IL-8. The levels of insulin and IL-8 were considerably elevated throughout (p &amp;lt; 0.001), total cholesterol, Low Density Lipoprotein (LDL), were significantly elevated (p &amp;lt; 0.001) in all patients as well. There was positive correlation between Interleukin-8 with LDL, while there was negative correlation with total cholesterol and High Density Lipoprotein (HDL). Interleukin-8 levels increase with obesity in patients and control groups, Interleukin-8 positively correlated with LDL-cholesterol and negatively correlated with HDL-C thus make us consider it as atherogenic factor, the increase in the level of IL-8 in patients who have diabetes mellitus may indicate increasing the incidence of atherosclerosis.</dc:description>
	<dc:publisher xml:lang="en-US">Atlanta Publishing House LLC</dc:publisher>
	<dc:date>2014-09-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://www.eurjchem.com/index.php/eurjchem/article/view/1084</dc:identifier>
	<dc:identifier>10.5155/eurjchem.5.3.529-531.1084</dc:identifier>
	<dc:source xml:lang="en-US">European Journal of Chemistry; Vol. 5 No. 3 (2014): September 2014; 529-531</dc:source>
	<dc:source>2153-2257</dc:source>
	<dc:source>2153-2249</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://www.eurjchem.com/index.php/eurjchem/article/view/1084/pdf_1084</dc:relation>
</oai_dc:dc>
			</metadata>
		</record>
	</GetRecord>
</OAI-PMH>
